<DOC>
	<DOCNO>NCT02392689</DOCNO>
	<brief_summary>Patients present Emergency Department shortness breath ( suspect ) heart failure screen randomize either standard care procalcitonin-guided arm . Procalcitonin-guided arm : procalcitonin level ( cutoff 0.2 ng/ml ) use support decision antibiotic therapy initiation . Standard care arm : decision antibiotic therapy base physician intent treat . The patient follow 30 90 day randomization evaluate survival status , re-hospitalizations antibiotic therapy .</brief_summary>
	<brief_title>Improve Management Heart Failure With Procalcitonin</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>1 . Patients present emergency department ( ED ) lead symptom dyspnea 2 . Suspected known heart failure 3. midregional pro atrial natriuretic peptide ( MRproANP ) &gt; 300 pmol/L , brain natriuretic peptid ( BNP ) &gt; 350 ng/ml Nterminal prohormone brain natriuretic peptide ( NTproBNP ) &gt; 1800 ng/l 4 . Patient give write Informed Consent within study timeline allow antibiotic therapy within 8 hour 5 . Adult patient ( i.e . &gt; 18 year age ) 6 . Hospitalization least 1 overnight stay plan 1 . Patient participate interventional clinical trial 2 . Trauma related shortness breath 3 . Patient diagnose lung thyroid cancer 4 . Known terminal disease life expectancy le 6 month , e.g . advanced metastasized cancer disease 5 . Organ transplant require immunosuppression 6 . Abdominal , vascular thorax surgery within last 30 day 7 . End stage/advanced heart failure define planned heart transplantation , cardiogenic shock 8 . Female patient give birth within 3 month study enrolment 9 . Current use antibiotic requirement immediate antibiotic therapy randomization measurement Procalcitonin 10 . End stage renal failure require dialysis 11 . Patient willing , possible advisable patient , follow study schedule , include antibiotic therapy 90 day follow 12 . Patient already participate clinical trial previously 13 . Pregnant lactate woman 14 . Patients institutionalized official judicial order 15 . Dependants sponsor , contract research organization ( CRO ) , study site investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>procalcitonin</keyword>
	<keyword>biomarker</keyword>
	<keyword>antibiotic therapy</keyword>
	<keyword>emergency department</keyword>
	<keyword>cardiology</keyword>
	<keyword>vitro diagnostics</keyword>
</DOC>